SCHEDULE 13G 0001603198 XXXXXXXX LIVE Common Stock, $0.001 par value 06/30/2025 0001611115 Omada Health, Inc. 68170A108 611 Gateway Blvd, Suite 120 South San Francisco CA 94080 Rule 13d-1(d) Andreessen Horowitz Fund IV, L.P. b DE 4210602.00 0.00 4210602.00 0.00 4210602.00 7.6 PN AH Equity Partners IV, L.L.C. b DE 4210602.00 0.00 4210602.00 0.00 4210602.00 7.6 OO AH Parallel Fund IV, L.P. b DE 403972.00 0.00 403972.00 0.00 403972.00 0.7 PN AH Equity Partners IV (Parallel), L.L.C. b DE 403972.00 0.00 403972.00 0.00 403972.00 0.7 OO Marc L. Andreessen b X1 0.00 4614574.00 0.00 4614574.00 4614574.00 8.3 IN Benjamin A. Horowitz b X1 0.00 4614574.00 0.00 4614574.00 4614574.00 8.3 IN Omada Health, Inc. 611 Gateway Blvd, Suite 120, South San Francisco, CA, 94080. The names of the persons filing this report (collectively, the "Reporting Persons") are: Andreessen Horowitz Fund IV, L.P. ("AH IV") AH Equity Partners IV, L.L.C. ("AH Equity IV") AH Parallel Fund IV, L.P. ("AH Parallel IV") AH Equity Partners IV (Parallel), L.L.C. ("AH Equity Parallel IV") Mark L. Andreessen ("Andreessen") Benjamin A. Horowitz ("Horowitz") The Reporting Persons expressly disclaim status as a "group" for purposes of this Schedule 13G. The address for each of the Reporting Persons is: Andreessen Horowitz 2865 Sand Hill Road, Suite 101 Menlo Park, CA 94025 AH IV Delaware AH Equity IV Delaware AH Parallel IV Delaware AH Equity Parallel IV Delaware Andreessen United States Horowitz United States Y Row 9 of each Reporting Person's cover page to this Schedule 13G sets forth the aggregate number of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. The Reporting Persons ownership of the Issuer's securities includes (i) 4,210,602 shares of common stock directly held by AH IV; and (ii) 403,972 shares of common stock directly held by AH Parallel IV. AH Equity IV is the general partner of AH IV and may be deemed to have sole power to vote and sole power to dispose of the shares of the Issuer held of record by AH IV for itself and as nominee of Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH IV for itself and as nominee. AH Equity Parallel IV is the general partner of AH Parallel IV and may be deemed to have sole power to vote and sole power to dispose of shares of the Issuer held of record by AH Parallel IV for itself and as nominee of AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. Andreessen and Horowitz are managing members of AH Equity Parallel IV and may be deemed to have shared voting and shared dispositive power over the shares held of record by AH Parallel IV for itself and as nominee. Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. The percentage set forth in each row 11 is based upon 55,744,340 shares of common stock outstanding as of June 9, 2025, as disclosed in the Issuer's prospectus dated June 5, 2025 filed with the Securities and Exchange Commission (the "SEC") on June 9, 2025. Row 5 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. Row 6 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to vote or to direct the vote of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. Row 7 of each Reporting Person's cover page to this Schedule 13G sets forth the sole power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. Row 8 of each Reporting Person's cover page to this Schedule 13G sets forth the shared power to dispose or to direct the disposition of securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2025 and is incorporated by reference. Y N Under certain circumstances set forth in the limited partnership agreements of each of AH IV and AH Parallel IV and the limited liability company agreements of AH Equity IV and AH Equity Parallel IV, the general partner and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the Issuer owned by each such entity of which they are a partner or a member, as the case may be. Y Y Y Y Exhibit 24.1 Power of Attorney for Marc L. Andreessen, dated June 23, 2023. Exhibit 24.2 Power of Attorney for Benjamin A. Horowitz, dated June 22, 2023. Exhibit 99.1 Joint Filing Agreement Andreessen Horowitz Fund IV, L.P. /s/ Phil Hathaway 08/14/2025 AH Equity Partners IV, L.L.C. /s/ Phil Hathaway 08/14/2025 AH Parallel Fund IV, L.P. /s/ Phil Hathaway 08/14/2025 AH Equity Partners IV (Parallel), L.L.C. /s/ Phil Hathaway 08/14/2025 Marc L. Andreessen /s/ Phil Hathaway 08/14/2025 Benjamin A. Horowitz /s/ Phil Hathaway 08/14/2025 Note 1: Andreessen Horowitz Fund IV, L.P. for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P. and Andreessen Horowitz Fund IV-Q, L.P. Note 2: AH Parallel Fund IV, L.P. for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B L.P. and AH Parallel Fund IV-Q, L.P.